If you liked this article you might like

Eli Lilly Acquires CoLucid Pharma, Adds Migraine Drug to Pipeline
Stock Futures Seek Direction After Trump Rally Fades
Patent Victory Secures Lilly Hold on Cancer Drug Until 2022
4 Biotech Names That Could Be M&A Targets